Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk

C Borghi, D Agnoletti, AFG Cicero, E Lurbe… - Hypertension, 2022 - Am Heart Assoc
Uric acid is the final product of purine metabolism, and its increased serum levels have been
directly involved in the pathogenesis and natural history of hypertension. The relationship …

Mendelian randomization as a tool for cardiovascular research: a review

MG Levin, S Burgess - JAMA cardiology, 2024 - jamanetwork.com
Importance Mendelian randomization (MR) is a statistical approach that has become
increasingly popular in the field of cardiovascular disease research. It offers a way to infer …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease

W Zhou, M Kanai, KHH Wu, H Rasheed, K Tsuo… - Cell Genomics, 2022 - cell.com
Biobanks facilitate genome-wide association studies (GWASs), which have mapped
genomic loci across a range of human diseases and traits. However, most biobanks are …

Association of serum uric acid with all-cause and cardiovascular mortality in diabetes

B Li, L Chen, X Hu, T Tan, J Yang, W Bao… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE To investigate whether serum uric acid (SUA) level is associated with all-cause
and cardiovascular disease (CVD) mortality among individuals with diabetes. RESEARCH …

Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care

HK Choi, N McCormick, C Yokose - Nature Reviews Rheumatology, 2022 - nature.com
Gout is a common hyperuricaemic metabolic condition that leads to painful inflammatory
arthritis and a high comorbidity burden, especially cardiometabolic-renal (CMR) conditions …

[HTML][HTML] Flexible electronics for cardiovascular healthcare monitoring

T Zhang, N Liu, J Xu, Z Liu, Y Zhou, Y Yang, S Li… - The …, 2023 - ncbi.nlm.nih.gov
Cardiovascular diseases (CVDs) are one of the most urgent threats to humans worldwide,
which are responsible for almost one-third of global mortality. Over the last decade, research …

Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study

S Yuan, J Chen, X Li, R Fan, B Arsenault, D Gill… - European journal of …, 2022 - Springer
The risk factors for nonalcoholic fatty liver disease (NAFLD) have not been clearly identified.
We conducted a Mendelian randomization (MR) study to explore this. Independent genetic …

[HTML][HTML] Uric acid and chronic kidney disease: still more to do

RJ Johnson, LGS Lozada, MA Lanaspa, F Piani… - Kidney International …, 2023 - Elsevier
Gout and hyperuricemia are present in 25% and 60% of patients with chronic kidney
disease (CKD), respectively. Despite the common association, the role of uric acid in the …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …